Literature DB >> 2171792

Postoperative neuromuscular block following atracurium or alcuronium in children.

O A Meretoja1, R Gebert.   

Abstract

Postoperative neuromuscular block (NMB) was evaluated in 60 children who received randomly either atracurium or alcuronium to induce and maintain an 85-95 per cent NMB during balanced anaesthesia. The EMG-monitor was turned away from the anaesthetist 10-15 min before the end of surgery. The average NMB was comparable between the groups at the time of reversal with neostigmine 50 micrograms.kg-1 (84 +/- 9 per cent, mean +/- SD) as were the NMB and the train-of-four ratio when the tracheas were extubated on a clinical basis (32 +/- 20 per cent and 50 +/- 18 per cent, respectively). Patients who had been paralyzed with atracurium arrived at the recovery room earlier and on arrival had greater train-of-four ratios than the patients paralyzed with alcuronium (P less than 0.01). Time to a train-of-four ratio of greater than 90 per cent was significantly shorter in the atracurium group (10 +/- 5 min vs 26 +/- 15 min, P less than 0.001). Thus, an intermediate-acting muscle relaxant offers a safer recovery profile of the NMB than a long-acting muscle relaxant in paediatric patients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2171792     DOI: 10.1007/BF03006532

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  13 in total

1.  The effect of tubocurarine on indirectly elicited train-of-four muscle response and respiratory measurements in humans.

Authors:  H H Ali; R S Wilson; J J Savarese; R J Kitz
Journal:  Br J Anaesth       Date:  1975-05       Impact factor: 9.166

2.  How should residual neuromuscular blockade be detected?

Authors:  R D Miller
Journal:  Anesthesiology       Date:  1989-03       Impact factor: 7.892

Review 3.  Pharmacokinetics of the nondepolarizing neuromuscular relaxants applied to calculation of bolus and infusion dosage regimens.

Authors:  C A Shanks
Journal:  Anesthesiology       Date:  1986-01       Impact factor: 7.892

4.  Clinical neuromuscular pharmacology of pancuronium.

Authors:  R L Katz
Journal:  Anesthesiology       Date:  1971-06       Impact factor: 7.892

5.  The margin of safety of neuromuscular transmission in the muscle of the diaphragm.

Authors:  B E Waud; D R Waud
Journal:  Anesthesiology       Date:  1972-10       Impact factor: 7.892

6.  Postoperative neuromuscular blockade: a comparison between atracurium, vecuronium, and pancuronium.

Authors:  D R Bevan; C E Smith; F Donati
Journal:  Anesthesiology       Date:  1988-08       Impact factor: 7.892

7.  Postoperative neuromuscular function.

Authors:  G H Beemer; P Rozental
Journal:  Anaesth Intensive Care       Date:  1986-02       Impact factor: 1.669

8.  Residual curarisation: a comparative study of atracurium and pancuronium.

Authors:  B N Andersen; J V Madsen; B A Schurizek; B Juhl
Journal:  Acta Anaesthesiol Scand       Date:  1988-02       Impact factor: 2.105

9.  Residual curarization in the recovery room: atracurium versus gallamine.

Authors:  P Howardy-Hansen; J A Rasmussen; B N Jensen
Journal:  Acta Anaesthesiol Scand       Date:  1989-02       Impact factor: 2.105

10.  Spontaneous recovery of neuromuscular function after atracurium in pediatric patients.

Authors:  O A Meretoja; I Kalli
Journal:  Anesth Analg       Date:  1986-10       Impact factor: 5.108

View more
  3 in total

1.  Recovery of neuromuscular function after atracurium and pancuronium maintenance of pancuronium block.

Authors:  D G Whalley; B Lewis; N M Bedocs
Journal:  Can J Anaesth       Date:  1994-01       Impact factor: 5.063

2.  Vigilance: the behavioral impact of quantitative monitoring on administration and antagonism of neuromuscular blocking agents.

Authors:  Anastasia D Grivoyannis; Virginia Tangel; Cynthia A Lien
Journal:  J Clin Monit Comput       Date:  2021-06-22       Impact factor: 1.977

3.  The efficacy and safety of sugammadex for reversing postoperative residual neuromuscular blockade in pediatric patients: A systematic review.

Authors:  Guangyu Liu; Rui Wang; Yanhong Yan; Long Fan; Jixiu Xue; Tianlong Wang
Journal:  Sci Rep       Date:  2017-07-18       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.